期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

他汀类药物在慢性充血性心力衰竭中的应用 被引量：5

暂未订购
导出
摘要 在美国，20岁以上人群中估计有570万人患有慢性充血性心力衰竭（chronicheartfailure．CHF），其中，大约50％心力衰竭（HF）的患者在确诊后5年内死亡。
作者 梁建文 伍贵富
机构地区 深圳市第四人民医院福田医院心血管内科
出处 《岭南心血管病杂志》 2013年第1期14-16,23,共4页 South China Journal of Cardiovascular Diseases
关键词 心力衰竭 充血性 脂蛋白类 胆固醇 他汀类药物
分类号 R541.61 [医药卫生—心血管疾病]
  • 相关文献

参考文献20

  • 1ROGER V L,GO A S,LLOYD-JONES D M,et al. Heartdisease and stroke statistics-2012 update : a report from theAmerican Heart Association [ J]. Circulation , 2012, 125(1):e2-e220.
  • 2SACKS F M , PFEFFER M A,MOYE L A,et al. The effect ofpravastatin on coronary events after myocardial infarction inpatients with average cholesterol levels. Cholesterol andRecurrent Events Trial Investigators[J]. N Engl J Med, 1996,335(14): 1001-1009.
  • 3SHEPHERD J, COBBE S M,FORD I,et al. Prevention ofcoronary heart disease with pravastatin in men withhypercholesterolemia. West of Scotland Coronary PreventionStudy Group [J]. N Engl J Med, 1995, 333(20) : 1301-1307.
  • 4FONAROW G C. Randomized clinical outcome trials of statinsin heart failure[J]. Heart Fail Clin,2008, 4(2): 225-229.
  • 5RIDKER P M, DANIELSON E, FONSECA FA, et al.Rosuvastatin to prevent vascular events in men and women withelevated C~reactive protein[J]. N Engl J Med, 2008, 359(21):2195-2207.
  • 6LEVINE B, KALMAN J, MAYER L, et al. Elevatedcirculating levels of tumor necrosis factor in severe chronicheart failure [J]. N Engl J Med, 1990, 323(4) : 236-241.
  • 7TORRE-AMIONE G,KAPADIA S, LEE J, et al. Tumornecrosis factor-alpha and tumor necrosis factor receptors in thefailing human heart [J]. Circulation, 1996, 93(4) : 704-711.
  • 8SETA Y,SHAN K , BOZKURT B , et al. Basic mechanisms inheart failure : the cytokine hypothesis [ J]. J Card Fail, 1996 ,2(3): 243-249.
  • 9TARANTINO G, CONCA P, BASILE V, et al. A prospectivestudy of acute drug-induced liver injury in patients sufferingfrom non-alcoholic fatty liver disease [ J ]. Hepatol Res , 2007,37(6): 410-415.
  • 10RAUCHHAUS M, COATS A J, ANKER S D. The endotoxin-lipoprotein hypothesis [ J ]. Lancet, 2000 , 356 (9233 ) : 930-933.

同被引文献52

  • 1Michael S Kostapanos,Moses S Elisaf.JUPITER and satellites:Clinical implications of the JUPITER study and its secondary analyses[J].World Journal of Cardiology,2011,3(7):207-214. 被引量：8
  • 2李玉贤,孟庆华.生物电阻抗技术在肝病病人人体成分测量中的应用[J].肠外与肠内营养,2006,13(4):240-242. 被引量：17
  • 3Balestrieri ML, Balestrieri A, Mancini FP, et al. Understanding the immunoangiostatic CXC chemokine network [J]. Cardiovasc Res, 2008,78(2) :250-256.
  • 4Bagnato G, Bitto A, Pizzino G, et al. Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis [J]. Rheumatology (Oxford), 2013, 52(8):1377-1386.
  • 5Wu IT, Zhang BF, Ye F, et al. A potential role for caveolin-I in VEGF-induced fibronectin upregulation in mesangial cells: involvement of VEGFR2 and Src [J]. Am 1 Physiol Renal Physiol, 2013,304: F820-F830 .
  • 6Lin WC, Lin CF, Chen CL, et al. Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators [J]. Exp Bioi Med, 2010,235(1): 57-65.
  • 7Soares AB, Demasi AP, Tincani AJ, et al. The increased PDGFA, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma [J]. 1 Clin Pathol, 2012,65:272 - 277.
  • 8Gazzerro P, Proto MC, Gangemi G, et al. Pharmacological actions of statins , A critical appraisal in the management of cancer [J]. Pharmacol Rev, 2012,64: 102-146.
  • 9Heiker JT. Vaspin(serpinA12) in obesity, insulin resistance, and inflammation [J]. J Pept Sci, 2014,20(5) :299-306.
  • 10Zhang B, Peng W, Li H, et al. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions [J]. Clin Biochem, 2013,46 (15) : 1520-1525.

引证文献5

二级引证文献142

岭南心血管病杂志
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部